ArticleDrugs in R&D2018

Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment.

John Marcinak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.